SLC13A5 and hyperlipidemia: As the glucagon/insulin ratio in terms of biological activity is increased in uncontrolled type 2 diabetes, the glucagon-dependent induction of SLC13A5 expression in liver cells might contribute to hyperlipidemia associated with diabetes.